Africa Calls for Equitable Access to Long-Acting HIV Innovations At UNAIDS Meeting in Brazil

Africa Calls for Equitable Access to Long-Acting HIV Innovations At UNAIDS Meeting in Brazil

Nairobi — African countries have renewed calls for equitable, affordable, and timely access to long-acting HIV prevention and treatment innovations, warning that scientific breakthroughs alone will not end the epidemic without deliberate action to close access and affordability gaps. The call was made during a high-level UNAIDS meeting in Brazil, where Kenya’s National AIDS and…

Read More
Africa: Birth Control in Africa – Study Tracks the Use of Long-Acting Contraception in 26 Countries

Africa: Birth Control in Africa – Study Tracks the Use of Long-Acting Contraception in 26 Countries

Contraception, or birth control, can take a number of forms including drugs, devices, or surgery to prevent pregnancy. Methods can be long-acting or short-acting. Obasanjo Bolarinwa, who teaches public health and global healthcare management, unpacks his research into the use of long-acting contraceptives among sexually active women in 26 sub-Saharan African countries. What are the…

Read More
Africa: Momentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders’ Calls To Action

Africa: Momentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders’ Calls To Action

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly oral pill MK-8527 advances to Phase 3 trials in Africa  14 July 2025 (Kigali, Rwanda)  – IAS 2025, the 13th IAS Conference on HIV Science, opened today with a call to accelerate…

Read More